HEC Management GP LLC, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 2,424 shares at $60.06 ($146K) on 2019-09-11, disclosed to the SEC on 2019-09-13.
Open-market sale of $146k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.06 | 1,112 | $67K | 45.9% |
| 2 | $60.06 | 1,112 | $67K | 45.9% |
| 3 | $60.07 | 200 | $12K | 8.3% |
| Total | $60.06 avg | 2,424 | $146K | 100% |
| Filing → |
| EGRX | SELL | 2019-10-09 | $776K | — | Filing → |
| USAT | BUY | 2019-09-23 | $639K | — | Filing → |
| CATM | BUY | 2018-02-23 | $14.9M | — | Filing → |